Vixtimotamab Antibody
Vixtimotamab (AMV-564) is a bispecific TandAb antibody that simultaneously targets CD33 and CD3. It is a research tool for studying acute myeloid leukemia (AML), with applications in both in vitro cytotoxicity assays and in vivo xenograft models to evaluate T-cell mediated anti-leukemic activity.
Product Specifications
Target
Integrin
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog